Clinical Trial Update: Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China [Phase 3]

View source ↗

Summary

Phase 3 trial update for Rasagiline (Azilect) in levodopa-treated Parkinson's patients with motor fluctuations in China; completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-06-26